Next, to begin addressing the biological relevance of HNRNPA1 overexpression in breast cancers, we generated stable shRNA constructs to target HNRNPA1 expression in MCF7 and MDA-MB-231 cells (Fig. 5D) and tested these models for changes in their neoplastic phenotypes. Here, HNRNPA1 is linked to breast carcinoma.